ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

AL-S Pharma · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
amyotrophic-lateral-sclerosis
amyotrophic lateral sclerosis, familial amyotrophic lateral sclerosis, sporadic amyotrophic lateral sclerosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 846966
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.